Bota was invited to WEF 2024 Summer Davos: Next Frontiers for Growth
The 15th Annual Meeting of the New Champions (AMNC), also known as the “Summer Davos”, was held in Dalian, China, from June 25 to 27, 2024. This event gathered over 1,500 global leaders from politics, business, social groups, international organizations, academia, and the media. This year’s meeting focused on innovation and the entrepreneurial spirit, aiming to identify new drivers for global economic growth.
Dr. Cheryl Cui, co-founder and CEO of Bota Biosciences, was invited to speak at the “Letting Biotech Breathe” panel on June 26 and the “Next Steps from Chinese Innovators” panel on June 27. During these sessions, she explored current trends and future directions in technological innovations that are crucial for advancing a bio-circular economy.
Dr. Cheryl Cui, CEO and co-founder of Bota Biosciences
In the discussions, Dr. Cui highlighted the transformative power of biotechnology across various industries, from consumer goods to environmental protection. She shared her vision of biotechnological transformation as a catalyst for innovation that will revolutionize manufacturing processes and eventually become an integral part of people’s daily lives. She stressed that leveraging talent is essential for harnessing technology to address real-world challenges. Entrepreneurs and business leaders should bring together talents with aligned visions, create an environment of mutual trust and collaboratively solve interesting and practically valuable problems.
Also, Dr. Cui shared insights on how biotechnological companies can navigate the rapidly evolving technological landscapes. She noted that Bota stays abreast of emerging technological trends, striving to seamlessly integrate new technologies with the complexities of biology for innovative solutions. She believes that significant breakthroughs in biomanufacturing can be achieved through the intersection between biotechnology and information technology.
Despite the uncertainties facing the world, the vitality, foresight, and collaborative spirit among innovators are the key drivers of technological advancement and societal development. Bota will continue to play a significant role in this process, contributing to sustainable development and fostering a circular economy.
About Bota Biosciences
Bota Biosciences is a global leader in Physical AI-driven biomanufacturing, dedicated to making biotechnology a reliable and scalable engine of productivity. By integrating end-to-end capabilities in AI, synthetic biology, and industrialization, Bota pioneers a new paradigm in biomanufacturing research and production. Our world-leading Physical-AI driven biofoundry platform spans strain engineering, process development, and scale-up production—translating complex biology into scalable solutions for diverse industries, from food and nutrition to personal care and beyond. Bota partners with global customers to deliver greener, more efficient bio-solutions, accelerating industry-wide adoption and the transition to a sustainable future.